Marina Gertsenstein

Mount Sinai Hospital

Papers

1

Total Citations

41

H-Index

1

About

Marina Gertsenstein is a leading figure in mammalian embryology and reproductive biology, with a specialized focus on the molecular mechanisms governing early embryo development. Her most cited work, "Automated Microinjection of Recombinant BCL-X into Mouse Zygotes Enhances Embryo Development" (2011, 41 citations), represents a landmark contribution to the field. In this study, Gertsenstein demonstrated that introducing recombinant BCL-X protein into fertilized mouse oocytes via automated microinjection significantly improves cleavage rates, blastocyst formation, and implantation success. This finding directly addresses a fundamental challenge in assisted reproductive technologies: the reliance on ooplasmic factors established during oogenesis for proper developmental programming. By identifying BCL-X as a critical enhancer of embryo progression, her research bridges basic cell survival signaling with practical applications in embryology. Gertsenstein’s work has profound implications for improving in vitro fertilization outcomes and understanding the molecular underpinnings of developmental competence. Her innovative use of automated microinjection techniques also highlights her commitment to advancing precision and reproducibility in experimental embryology, making her a key contributor to both fundamental science and translational reproductive medicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
41
Total Citations
41
Avg Citations/Paper
🏆 Most Cited Paper
Automated Microinjection of Recombinant BCL-X into Mouse Zygotes Enhances Embryo Development
41 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Mount Sinai Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago